Results 41 to 50 of about 767 (176)
Hypoxia inducible factor 3‐alpha promotes a malignant phenotype in colorectal cancer cells
Abstract Colorectal cancer (CRC) is the third most common cancer worldwide. Hypoxia is a hallmark of the tumor microenvironment, and cellular adaptation to it is primarily mediated by the family of Hypoxia‐inducible factors (HIFs) HIF‐1α, HIF‐2α, and HIF‐3α. However, in contrast to HIF‐1α and HIF‐2α, a specific role for HIF‐3α in cancer biology has not
Alejandro Lopez‐Mejia +7 more
wiley +1 more source
Background and objectives: Adalimumab (ADA), a monoclonal humanised anti-TNF antibody, is usually prescribed as a second-line treatment in paediatric Crohn's disease (CD) patients who have become unresponsive or developed intolerance to infliximab (IFX).
Víctor Manuel Navas-López +7 more
doaj +1 more source
El uso prolongado de terapia anti-factor de necrosis tumoral es cada vez más frecuente en los pacientes con enfermedad inflamatoria intestinal.
J. Alberto Romero-Lozanía +5 more
doaj +1 more source
ABSTRACT Purpose Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency–funded project (EUPAS39322), defined a set of metadata to describe real‐world data sources (RWDSs) and piloted metadata collection in a prototype catalogue to assist investigators from data source discoverability ...
Romin Pajouheshnia +46 more
wiley +1 more source
Resumen: Introducción y objetivos: Adalimumab (ADA), anticuerpo anti-TNF-α monoclonal recombinante de origen humano, generalmente se emplea como tratamiento de segunda línea en niños con enfermedad de Crohn (EC) que no han respondido o han perdido ...
Víctor Manuel Navas-López +7 more
doaj +1 more source
Anemia y enfermedad inflamatoria intestinal [PDF]
La anemia es una de las complicaciones más comunes de la enfermedad inflamatoria intestinal. La alta frecuencia de valores bajos de hemoglobina en estos enfermos provoca en muchas ocasiones una infravaloración por parte del médico de esta circunstancia, lo que se traduce en la falta de un tratamiento eficaz.
Morena, F. de la, Gisbert, J. P.
openaire +3 more sources
This is the first Latin American Consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) regarding special situations in patients with inflammatory bowel disease (IBD).
J.K. Yamamoto-Furusho +15 more
doaj +1 more source
Resumen: La enfermedad inflamatoria intestinal pediátrica continúa siendo poco prevalente en nuestro medio. El comienzo de los síntomas puede ser insidioso y el diagnóstico precoz permite disminuir las complicaciones y las secuelas de la enfermedad, así ...
Javier Martín-de-Carpi +4 more
doaj +1 more source
Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis
Paediatric inflammatory bowel disease is not very common in Spain. Its onset can be silent and an early diagnosis reduces complications and sequelae related to the disease, and can improve the prognosis.
Javier Martín-de-Carpi +4 more
doaj +1 more source
Ueg Week 2020 Poster Presentations
United European Gastroenterology Journal, Volume 8, Issue S8, Page 144-887, October 2020.
wiley +1 more source

